In The News: School of Integrated Health Sciences

Healthline

New research published in the journal Nature Medicine reports that the popular artificial sweetener erythritol was found to be linked to a greater risk for cardiovascular events like heart attack and stroke.

United Press International

As little as a cup a day of strawberries can improve heart health, according to the Global Burden of Disease study.

EurekAlert!

As attention focuses on heart disease this February for American Heart Month, the latest research on strawberries, including their potential heart health benefits, was presented at the 9th biennial Berry Health Benefits Symposium (BHBS) in Tampa, FL. This research adds to the growing body of scientific evidence supporting the role of strawberry consumption in promoting heart health. 

Daily Mail

A new era of spaceflight has dawned with NASA's Artemis programme, which aims to establish a base camp on the moon and lay groundwork for a future trip to Mars. The US space agency will send humans back to the lunar surface in 2025, but its manned missions to the Red Planet won't take place until the 2030s. Meanwhile, billionaire entrepreneur Elon Musk thinks he can beat NASA to it by sending crewed flights to Mars as soon as the second half of this decade.

Drug Discovery News

In July 2022, a bombshell dropped on the Alzheimer's disease research field. For years, researchers had searched for something that caused the disease’s telltale amyloid plaques — complex tangles of a protein called amyloid-beta (Aβ) frequently found in the brains of patients with neurodegenerative disorders. A series of studies published starting in the mid-2000s reported the discovery of a toxic form of Aβ in the brains of mouse models of Alzheimer's disease called Aβ*56. Researchers hoped that Aβ*56 was the protein that snowballed into those amyloid plaques. But a team of sleuths found that many of the papers describing Aβ*56 were fraudulent and contained an array of faked images and blots. The fraud seemed to call the entire idea of amyloids causing Alzheimer’s disease into question.

Live Science

From sprinting to long distance, the body uses a lot of energy during running and eventually becomes fatigued. How often the feet hit the ground and at what angle can not only improve running efficiency, but potentially help prevent injury too. This is known as cadence — something that many of the best running watches now have the ability to track. But what cadence is best? And is it possible for someone to change their running cadence? We looked at the science.

Las Vegas Review Journal

A musical superstar has recruited a UNLV student for her effort to improve young people’s mental health. The Born This Way Foundation, co-founded in 2012 by Lady Gaga and her mother, Cynthia Germanotta, announced its new group of 31 advisory board members Tuesday, including Faria Tavacoli, a 20-year-old sophomore majoring in public health and minoring in neuroscience at UNLV.

Healthline

Gym-goers and athletes alike use many different compounds to help boost physical performance — from proteins to branched-chain amino acids. Another one that’s long been associated with improved exercise performance is dietary nitrate, a natural chemical that the body converts to nitric oxide. Research has shown it can improve muscle and cardiovascular function.

United Press International

Predicting when new drugs come to market in the United States has never been an exact science, and it has become even harder since the start of the COVID-19 pandemic, experts told UPI. But some drugs on the horizon have the potential to make a major impact.

Smithsonian Magazine

NASA is preparing to return astronauts to the lunar surface. And this time with more ambitious goals.

Supercluster

Those missions, which had a successful kickoff with Artemis-1, will establish the groundwork for months-long human habitation on the Lunar surface. Proposed base camps will present unique opportunities to test technology, unravel scientific secrets about the Moon's past and present, search for the presence of water, and more.

Alzheimer's News Today

AB Science is initiating a Phase 3 trial to evaluate the safety and efficacy of its candidate therapy masitinib in patients with mild to moderate Alzheimer’s disease.